Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Bayer, Millennium form the largest drug discovery alliance in history

Sep. 29, 1998

Tranzyme obtains technology license from U. of Alabama

Sep. 24, 1998

PowderJect delivery of DNA vaccines validated in preclinical study

Sep. 24, 1998

BTG licenses improved vaccine technology to Pasteur Merieux Connaught

Sep. 23, 1998

Lion and Infogen establish gene identification collaboration

Sep. 23, 1998

Genetronics reports continued success with electroporation therapy of cancer

Sep. 22, 1998

SB-234551 characterized as potent, selective, nonpeptide ETA receptor antagonist

Sep. 18, 1998

Nexell submits data requested by FDA

Sep. 18, 1998

First group 1 mGluR antagonist with submicromolar potency described by Lilly

Sep. 17, 1998

Inflammatory/immunological disease collaboration initiated by BMS and Molecumetics

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...